Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03529201Completed
Randomised, single-blind trial of ropivacaine in postoperative pain (2 arms), sponsored by Medical University of Lublin. Primary endpoint: Total consumption of oxycodone at 24 hours. Started May 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03529201.